United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - vancomycin hydrochloride - oral solution - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - vancomycin hydrochloride - oral suspension - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - vancomycin hydrochloride - oral capsule - 125mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

riemser pharma gmbh - vancomycin (vancomycin hydrochloride) - capsules hard - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

xellia pharmaceuticals aps - vancomycin hydrochloride - oral capsule - 125mg

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurocept international b.v. - vancomycin hydrochloride 262,5 mg - eq. vancomycin 250 mg - capsule, hard - 250 mg - vancomycin hydrochloride 262.5 mg - vancomycin

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - vancomycin hydrochloride - capsule - vancomycin hydrochloride 125 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

xellia pharmaceuticals aps - vancomycin hydrochloride - oral capsule - 250mg

Israel - English - Ministry of Health

bioavenir ltd, israel - vancomycin as hydrochloride - powder for solution for injection - vancomycin as hydrochloride 1 g/vial - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci.it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.

Israel - English - Ministry of Health

bioavenir ltd, israel - vancomycin as hydrochloride - powder for solution for injection - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci.it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.